DiaMedica Therapeutics
DMAC
DMAC
40 hedge funds and large institutions have $23.3M invested in DiaMedica Therapeutics in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 32 → 40 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.28% less ownership
Funds ownership: 13.34% → 13.05% (-0.28%)
Holders
40
Holding in Top 10
1
Calls
$200K
Puts
$7K
Top Buyers
| 1 | +$515K | |
| 2 | +$468K | |
| 3 | +$294K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$243K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$218K |
Top Sellers
| 1 | -$314K | |
| 2 | -$44.5K | |
| 3 | -$10.5K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.19K |
| 5 |
NMM
Naples Money Management
Naples,
Florida
|
-$3.81K |